Sehgal, K., Pappa, T., Shin, K., Liu, M., Pfaff, K. L., Barletta, J. A., Doherty, G. M., Alexander, E. K., Rodig, S., Hanna, G. J., Barbie, D. A., ONeill, A., Allen, E. M. V., Haddad, R. I., Lorch, J. H. (2025). Dual immune checkpoint inhibition in advanced incurable radioidine-refractory differentiated thyroid carcinoma (RAIR DTC), anaplastic (ATC), and medullary thyroid carcinoma (MTC): Long-term survival results from phase II clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6105